Manager, Shop Floor Quality Assurance, Cell Therapy in Devens, MA at Bristol-Myers Squibb

Devens, Massachusetts, United States

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Skills

Key technologies and capabilities for this role

cGMPQuality AssuranceShop Floor OversightCell TherapyManufacturing ComplianceQuality ControlWarehouse Operations

Questions & Answers

Common questions about this position

What is the work location and shift schedule for this role?

The role is stationed in Devens, MA and requires an onsite rotating schedule of 6am–6pm, including holidays and weekends.

What salary or compensation is offered for this position?

This information is not specified in the job description.

What are the key skills required for the Manager, Shop Floor Quality Assurance role?

Key skills include providing leadership for on-the-floor Quality oversight, comprehensive understanding of Cell Therapy processes for real-time decision-making, advanced ability to synthesize information, and ensuring compliance with Global cGMP and BMS policies.

What is the team structure for this position?

The role leads a team of 4-8 employees on the Shop Floor Quality Assurance team, which provides 24x7 Quality collaboration and oversight of site operations.

What does the company culture at Bristol Myers Squibb emphasize?

The culture is challenging, meaningful, and life-changing, with uniquely interesting work, opportunities to grow alongside high-achieving teams, and a focus on balance, flexibility, and reimagining cell therapy to transform patient lives.

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI